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The finding that group A  streptococci contain antigens that are immunologically 
cross-reactive with  human  heart  tissue  (1-8)  has  been  of considerable  concern to 
investigators  attempting  to  develop protective  vaccines against  strains  of group  A 
streptococci that are capable of initiating acute rheumatic fever and rheumatic heart 
disease.  Indeed, the presence of such cross-reactive antigens in various streptococcal 
products (1-8) has hampered efforts to vaccinate humans because of the theoretical 
danger that  the cross-reactive antigens may evoke heart-reactive immune responses 
and thereby elicit,  rather than prevent, rheumatic heart  disease.  Most of the cross- 
reactive antigens appear to be associated with components of the streptococcal cell 
wall  (2,  5,  6)  or cell  membrane  (3,  8), rather than with  the surface M  protein, the 
type-specific antigen of group A streptococci that evokes protective immunity. Thus, 
Zabriskie  and  Freimer  (3)  described  heart  cross-reactive antibodies  in  the  sera  of 
rabbits immunized with streptococcal protoplast membranes. Because the antibodies 
could be removed by absorption with membranes from streptococci of heterologous 
as well as homologous serotypes, it was assumed that heart cross-reactive antibodies 
were not associated with the type-specific M  protein. That more than one protoplast 
membrane  antigen  may be  involved in  these  cross-reactions was  suggested by the 
studies  of van  de  Rijn  et  al.  (8),  who  showed  that  the  antibodies  in  the  sera  of 
membrane-immunized rabbits reacted with different antigenic determinants of heart 
tissue than did the sera from some subjects with rheumatic fever. Similar non-type- 
specific  heart  cross-reactive  antigens  were  shown  to  be  associated  with  cell  wall 
preparations of group A streptococci (5). 
In addition to these studies, however, Kaplan (2, 5, 6) demonstrated an additional 
heart  cross-reactive antigenic determinant(s)  associated with  the  cell  wall  that  was 
restricted to types 5 and 19 streptococci. Furthermore, this heart cross-reactive antigen 
was copurified with acid extracts of the M  proteins from these serotypes (2).  Similar 
type-specific cross-reactions were  reported by Lyampert et  al.  (7),  who immunized 
rabbits with types 1 and 5 streptococci. In none of these studies, however, was it shown 
that the cross-reactive determinants resided in the M  protein molecule itself.  Indeed, 
Kaplan concluded they did not, because type-specific M  antigens could be separated 
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from  the  heart  cross-reactive antigen, although  the  heart-reactive  antigen seemed 
inseparable from an additional type-specific antigen (2). 
Now that new methods of extraction and purification have yielded homogeneous 
preparations of M  protein and it has been demonstrated that  native and synthetic 
peptide  fragments  of the  M  protein  molecule  are  immunogenic (9-14),  we  have 
undertaken studies to examine in detail the structural relationships of the M  protein 
molecule to heart  tissue cross-reactive antigens. In this report, we present definitive 
evidence that at least one protective antigenic determinant of a  structurally defined 
polypeptide fragment of type 5  M  protein evoked antibody that  cross-reacted with 
sarcolemmal membranes of human heart muscle; the cross-reactive antibody eluted 
from  the  sarcolemmal  membranes  opsonized  both  types  5  and  19  streptococci, 
indicating that  the  heart  cross-reactive determinant of type  5  M  protein is shared 
with  type  19  M  protein. The purified antibody was  used  in an affinity column to 
isolate a sarcolemmal membrane protein ("215,000 tool wt) shown to be cross-reactive 
with types 5 and 19 M  proteins. 
Materials and Methods 
Extraction and Purification of M  Protein.  M  proteins were purified from limited peptic digests 
of types 5, 6,  19, and 24 streptococci as previously described (9-11). The purified products, 
designated  pep  M  proteins,  were judged  to  be  homogeneous by  sodium  dodecyl  sulfate- 
polyacrylamide gel  electrophoresis  (SDS-PAGE)  (9).  I  The  details  of  the  purification and 
characterization of type  19 M  protein (pep M19), not previously reported, will be reported 
elsewhere  (E. H. Beachey and J. M. Seyer, manuscript in preparation). 
Preparation of Cell  Walls  and Protoplast Membranes.  Cell wails were prepared  by rupturing 
whole type 6 streptococci with glass beads in a Braun MSK homogenizer (Arthur H. Thomas 
Co.,  Philadelphia, PA)  followed  by differential centrifugation and washing as  described by 
Bleiweis et al. (15). Cell membranes were prepared from protoplasts produced by treating whole 
type 30 streptococci  with group C bacteriophage-associated lysin as described by Zabriskie and 
Freimer (3). 
Immunization of  Animals.  New Zealand White rabbits were immunized intracutaneously  with 
100 #g pep  M5 emulsified in complete Freund's adjuvant (12). Serum was obtained before 
immunization  and at 2-wk intervals thereafter. Some animals received additional injections of 
100/~g pep M5 in incomplete Freund's adjuvant, and serum was again collected at 1- and 2-wk 
intervals. 
Detection of M  Protein Antibodies.  All sera were tested for type-specific and cross-reactive M 
antibodies by an enzyme-linked immunosorbent assay  (ELISA) as  previously described  (13, 
14). ELISA titers are expressed  as  the reciprocal of the highest dilution of serum giving an 
absorbence of >0.1 at 405 nm. 
Type-specific and cross-reactive  opsonic antibodies were detected by in vitro opsonophago- 
cytic assays as described elsewhere  (9). Briefly, the test mixture consisted of 0.4 ml fresh human 
blood supplemented with 10 U/ml of heparin, 0.05 ml of a standard suspension of streptococci, 
and 0.I ml of test serum. The percentage of neutrophils with associated streptococci (percent 
phagocytosis)  was estimated by microscopic counts of stained smears prepared from the assay 
mixtures after rotating at 37°C for 45 rain. Indirect bactericidal tests were performed using the 
same test mixtures as described above except fewer colony-forming  units of streptococci (CFU) 
were  added  (16). The mixtures were  rotated at  37°C for  3 h,  after which pour plates were 
prepared by adding the test mixtures to 20 ml of 5% sheep  blood agar (16). 
Detection of Tissue Cross-Reactive Antibodies.  Sarcolemmal membrane sheaths were prepared 
from fresh human heart by the method of van de Rijn et al.  (8). The lyophilized membranes 
Abbreviations used in this paper: pep M, purified pepsin extracts of types 5, 6, 19 and 24 streptococci; 
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were mixed with distilled water, and one drop was placed on microscope slides, allowed to dry, 
and stored at -70°C. Before use, the samples were fixed in  1% paraformaldehyde for 3 rain. 
Sarcolemmal cross-reactive antibodies were detected by  indirect  immunofluorescence as  de- 
scribed previously (17). Briefly, preimmune and immune rabbit sera were diluted 1:4 with 0.02 
M  phosphate/0.15 M  NaCI, pH 7.4 (PBS)  and allowed to react with sarcolemmal membranes 
for 30 min at ambient temperature. After washing three times for 5 rain in PBS, the antibody- 
treated tissue was incubated with a  1:40 dilution of fluorescein-labeled goat anti-rabbit IgG (N. 
L. Cappel Laboratories Inc., Cochranville, PA), again washed three times in  PBS, and then 
mounted with one drop of 1% Gelvatol, pH 7.0 and a coverslip. The tissue was examined under 
a fluorescence microscope (E. Leitz, Inc., Rockleigh, N  J). In addition, the specificity of tissue 
cross-reactive antibodies was determined by indirect immunofluorescence as described above 
using frozen sections  (4-/tm  thick)  of human  lung, kidney,  liver, brain,  skeletal muscle, and 
heart, which were obtained at autopsy. 
Immunoabsorption of Test Sera.  In some experiments, the test sera were first absorbed with an 
equal packed volume of freshly cultured and PBS-washed streptococci or sarcolemmal mem- 
branes. Serum was also absorbed with cell membranes of type 30 streptococci and cell walls of 
type 6 organisms, each at a concentration of 4 mg/ml. All immunoabsorptions were performed 
at  37°C for  1 h,  then 4°C for  18  h.  Inhibition experiments were performed by first adding 
purified M  protein (1  mg/ml) or a  tropomyosin (4 mg/ml) to the test sera before performing 
opsonophagocytic or immunofluorescence assays. 
Cross-reactive antibodies were eluted from sarcolemmal membranes by the following proce- 
dure.  3  ml  of immune  rabbit  serum  was  absorbed  with  250  mg  lyophilized sarcolemmal 
membranes  as  described above. The mixture was centrifuged at  500 g  for  15  min,  and  the 
absorbed  serum was retained. The membrane pellet was washed  three times with  PBS and 
then rotated in 5 ml of 0.2 M  glycine/0.2 M  NaCI, pH 2.8 for 30 min at ambient temperature. 
The  membranes  were  removed  by  centrifugation,  and  the  supernatant  containing  eluted 
antibodies was dialyzed against PBS overnight. The sample was concentrated to a final volume 
of 1 ml by membrane filtration (YM 30  membrane; Amicon Corp., Scientific Systems Div., 
Lexington, MA). 
Purification of Heart-reactive Antibodies.  Because previous immunoabsorption experiments had 
shown that only heart-reactive antibodies in the pep M5 antiserum reacted with the heterolo- 
gous  pep  M19  antigen,  heart-reactive antibodies were purified by  affinity chromatography 
using pep M19 immobilized on agarose beads. 
Pep M19 (10 mg) was conjugated to cyanogen bromide-activated Sepharose 4B (Pharmacia, 
Uppsala, Sweden) by the method of March et al.  (18).  Free antigen was removed from the 
beads by washing alternately with 0.1  M  acetate buffer, pH 4.0, and 0.1 M  borate buffer, pH 
9.4.  The beads  were suspended  in  PBS and  packed  into a  1 ×  30-cm column  (Pharmacia). 
After equilibrating the column with PBS, 3 ml of immune serum was applied and allowed to 
incubate for 30 min at ambient temperature.  Serum proteins were eluted with PBS until the 
protein  concentration,  as  measured  by  ultraviolet  absorption  at  a  wavelength of 230  nm, 
reached baseline. Specific pep M19 antibody was eluted with 0.2 M  glycine/0.2 M  NaC1, pH 
2.8. The antibody-containing fractions were dialyzed against 0.15  M  NaC1  and concentrated 
by membrane filtration (YM 30 membrane; Amicon Corp.). The titer of antibody against pep 
M19 was determined by ELISA, and the presence of heart-reactive antibodies was confirmed 
by indirect immunofluorescence using sarcolemmal membrane sheaths as described above. 
Purification of Human Heart Antigen.  The purified antibody obtained above was immobilized 
on agarose beads by the following method.  10 ml of CH-Sepharose 4B was mixed with 5 ml 
purified antibody, which had been adjusted to pH 4.5. To this was added 100 mg carbodiimide, 
which was dissolved in 5 ml distilled water and adjusted to pH 4.5. The mixture was rotated 
for 18 h at ambient temperature, after which the beads were washed extensively with distilled 
water and packed into a  1 ×  30-cm column (Pharmacia). The antibody-Sepharose column was 
then equilibrated with PBS. 
Sarcolemmal membrane antigens were extracted by adding  1 ml of 1% SDS to 250 mg of 
sarcolemmal membranes. The mixture was placed in a boiling water bath for 2 min and then 
centrifuged for 5 min  in an  Eppendorf microfuge (Brinkmann  Instruments,  Inc., Westbury, 
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Sepharose column. Excess proteins were eluted with PBS, and after the protein concentration 
reached baseline, specific  antigen was  eluted with 0.2  M  glycine/0.2 M  NaCI, pH  2.8. The 
fraction containing  the eluted antigen was dialyzed against PBS and concentrated by membrane 
filtration. 
Purity of the  sarcolemmal membrane antigen was  assessed  by SDS-PAGE as  described 
previously (9). Some samples were subjected to reducing conditions by boiling in sample buffer 
containing 1% fl-mercaptoethanol. Polyacrylamide gels were stained with silver nitrate reagent 
(Bio-Rad Laboratories, Richmond, CA) according to the manufacture's instructions  with minor 
modifications. For autoradiographic analysis, the proteins were transferred to nitrocellulose- 
paper using an Electroblot apparatus (E-C Apparatus Corp., St. Petersburg, FL) by the method 
of Towbin et al. (19). The nitrocellulose paper was preincubated in 0.05 M Tris/0.15 M NaC1, 
pH  7.4  with  1%  bovine serum  albumin (Tris-BSA)  at  37°C  for  1 h  to  reduce nonspecific 
antibody binding. The paper was treated with heart-reactive antiserum, diluted 1:250 in Tris- 
BSA for 2 h at 37°C, and washed extensively with 0.15 M  NaC1. The nitrocellulose was then 
reacted with  12~I-protein A  (New  England Nuclear, Boston, MA)  (sp. act.  70-100 #Ci/mg, 
diluted in Tris-BSA to 200,000 CPM/ml) at 37°C for 2 h. After extensive washing, the paper 
was dried and exposed  to Kodak X-ray film (Eastman Kodak Co., Rochester, NY) for 36 h. 
Results 
Heart Cross-Reactive  Antibodies Evoked by Immunization  with pep M5.  One of the first 
three rabbits immunized with pep M5 developed antibody cross-reactive with human 
sareolemmal  membranes  (Table I).  All  three  rabbits showed  strong M5  antibody 
responses by both ELISA and opsonophagoeytie tests (Table I). None of an additional 
six  rabbits immunized with  pep  M5  developed heart-reactive antibodies, although 
each showed strong M5 immune responses (data not shown), suggesting that the heart 
TABLE  I 
Type-specific and Heart-reactive Antibodies Raised in Rabbits 
Immunized with pep M5 
Immune rabbit  ELISA titer  Percent  phagocy-  Sarcolemmal 
tosis of type 5  fluorescence  serum  against pep M5  streptococci* 
7907  51,200  92  +++ 
7908  102,400  62  0 
7909  >102,400  80  0 
Preimmune pool~  <200  2  0 
* Percent phagocytosis equals the  percentage of neutrophils that  ingested 
streptococci. 
:~ Preimmune sera from rabbits 7907, 7908, and 7909. 
TABLE II 
Specificity of Tissue Cross-Reactive Antibodies Raised against Type 5 M 
Protein Measured by Indirect Immunofluorescence 
Tissue  Immunofluorescence 
Heart  +++ 
Skeletal muscle  +++ 
Smooth muscle (arteriolar)  0 
Kidney  0 
Brain  0 
Lung  0 
Liver  0 JAMES B.  DALE AND EDWIN H. BEACHEY  1169 
cross-reactive determinant in pep M5 preparations is a minor antigenic determinant. 
Tissue Specificity of Heart Cross-Reactive Antibody.  Immunofluorescence tests of frozen 
sections of human heart, skeletal muscle, kidney, liver, lung, and brain were positive 
only with heart and skeletal muscle (Table II). These tissues  immunofluoresced in a 
sarcolemmal distribution  similar  to that  previously reported  for other streptococcal 
cross-reactive antibodies (2, 3). 
Opsonization of Type  19 Streptococci by Heart  Cross-Reactive Antibody.  Because earlier 
studies  by  Kaplan  (2)  had  suggested  a  relationship  between  tissue  cross-reactive 
antigens of types 5  and  19 streptococci, the pep  M5  antisera were  tested  for their 
ability  to  opsonize type  19  streptococci  (Table  III). Only the  heart  cross-reactive 
antiserum  (7907) was able to opsonize the heterologous type 19 organisms. Neverthe- 
less, none of six rabbits immunized with  100 #g of pep M19 emulsified in complete 
Freund's adjuvant developed heart cross-reactive antibodies, although each developed 
type 19 opsonic antibodies (E. H. Beachey and J. H. Seyer, manuscript in preparation). 
The pep M5 heart cross-reactive antiserum  (7907)  was used in the following studies. 
Absorption of Opsonic Antibodies  by pep  M  Proteins and Sarcolemmal Membranes.  The 
above studies  suggested that the pep M5 antibodies that cross-reacted with human 
heart tissue may be directed against opsonic antigenic determinants on types 5 and 19 
M proteins. To test this hypothesis, the cross-reactive serum was absorbed with human 
heart tissue,  pep M5 or pep MI9, and then assayed in opsonophagocytic tests with 
type 5 or type  19 streptococci  (Table  IV). As expected,  opsonic antibodies  against 
type 19 streptococci were totally inhibited by pep M5, the immunizing antigen, and 
TABLE III 
Cross-Reactive Opsonic Antibodies against Type 19 Streptococci in pep M5 
Immune Rabbit Serum 
Immune rabbit serum 
Percent phagocytosis  of: 
Type 5  Type 19 
streptococci  streptococci 
7907  92  96 
7908  62  6 
7909  80  10 
Preimmune pool  2  2 
TABLE IV 
Absorption of Heart Cross-Reactive Opsonic Antibodies  from Rabbit Antiserum 
7907 with Purified  pep M Proteins and Human Heart Tissue 
Percent  Phagocytosis test organism  Serum  absorbed with:  phagocytosis 
Type 19 streptococci  Unabsorbed  78 
pep M5  2 
pep M19  0 
Human Heart  4 
Type 5 streptococci  Unabsorbed  72 
pep M5  2 
pep M19  86 
Human heart  72 1170  M PROTEIN HEART TISSUE CROSS-REACTION 
by pep M19, the homologous test antigen. Absorption with sarcolemmal membranes 
similarly reduced opsonization of type 19 streptococci, suggesting that the heart cross- 
reactive antibodies were raised  against  a  protective antigenic determinant of type 5 
M  protein  that  is  shared  with  type  19  M  protein.  In  contrast,  opsonic antibodies 
directed  against  type  5  streptococci  were  inhibited  only  by  pep  M5  (Table  IV), 
indicating  the  presence  on  type  5  M  protein  of  additional  protective  antigenic 
determinants that are not heart cross-reactive. 
Absorption  of Heart-reactive  Antibody  by pep  M  Proteins,  Streptococcal  Cells,  and  Heart 
Tissue.  The specificity of the  cross-reactive antibodies  raised  against  pep  M5  was 
assessed by the ability of  various immunoabsorbents to inhibit the fluorescent antibody 
reaction  against  sarcolemmal membranes  (Table  V).  Of the  many whole  group A 
streptococci tested, only types 5 and 19 absorbed the tissue cross-reactive antibody. In 
agreement with opsonic inhibition tests (see above), pep M5 and pep M 19 completely 
inhibited the sarcolemmal immunofluorescence, whereas pep M6 and pep M24 had 
no effect (Table V). Absorption of the serum with cell walls of type 6 and cytoplasmic 
membranes  of type  30  streptococci  failed  to  inhibit  immunofluorescence.  Finally, 
because previous studies have indicated structural similarities between a  tropornyosin 
of heart tissue and streptotoccal M  proteins  (20),  we tested the ability of purified a 
tropomyosin  derived  from  rabbit  heart  to  inhibit  the  binding  of  heart-reactive 
antibody to sarcolemmal membranes.  Concentrations up to 4 mg/ml failed to alter 
the immunofluorescence reaction (Table V). 
Elution of Opsonic Antibodies Adsorbed  to Sarcolemmal  Membranes.  To provide further 
evidence that the heart-reactive antibodies raised against pep M5 were opsonic, the 
serum was absorbed with sarcolemmal membranes, and the adsorbed antibodies were 
then eluted at pH 2.8 and tested for opsonophagocytic activity against types 5 and  19 
streptococci (Table VI). Absorption of the pep M5 antiserum with heart tissue totally 
removed opsonic antibodies against type 19 streptococci, but only partially removed 
antibodies  directed  against  type  5  organisms  (Table  VI).  Antibodies  eluted  from 
sarcolemmal  membranes  opsonized  both  types  5  and  19  organisms  (Table  VI). 
Bactericidal  activity of the  eluted  antibody was retained  as  indicated  by the  total 
TABLE V 
Type-specific Absorption of Heart-reactive Antibodies  from Rabbit Antiserum 
7907 by Type 5 Streptococci, Type 19 Streptococci, pep M5, and pep M19 
Sarcolemmal  Serum absorbed with:  fluorescence 
Unabsorbed  +++ 
Type 5 streptococci  0 
Type 19 streptococci  0 
Other serotypes*  +++ 
Type 6 cell walls  +++ 
Type 30 cytoplasmic  membranes  +++ 
pep M5  0 
pep M19  0 
pep M6  +++ 
pep M24  +++ 
Heart tissue  0 
t~ tropomyosin  +++ 
* Group A streptococcal serotypes 1, 2, 3, 6, 12, 14, 24, 30, 31, 49, 55, and 56. JAMES B. DALE AND EDWIN H. BEACHEY 
TABLR VI 
Opsonization of Types 5 and 19 Streptococci by Heart-reactive Antibody Eluted 
from Human Heart Tissue 
Serum 
Percent phagocytosis of: 
Type 5 strep-  Type 19 strep- 
tococci  tococci 
Normal rabbit serum  10  4 
7907  82  96 
7907  absorbed with  sarcolemmal  mem-  66  4 
branes 
Heart-reactive antibodies eluted from sar-  62  94 
colemmal membranes 
1171 
TABLE  VII 
Bactericidal Activity against Type 19 Streptococci of Heart-reactive Antibodies 
Eluted from Human Heart Tissue 
Serum 
CFU of type 19 streptococci 
surviving 3-h rotation in test 
mixture 
Inoculum  194  Inoculum 85 
Normal rabbit serum  >2,000  >2,000 
7907  0  0 
7907  absorbed  with  sarcolemmal  mem-  444  113 
branes 
Heart-reactive antibodies eluted from sar-  0  0 
colemmal membranes 
killing of type  19  organisms  after  3  h  incubation  in  the  bactericidal  test  mixture 
(Table VII). 
Purification  of the Cross-Reactive Antigen from Sarcolemmal  Membranes.  The sarcolemmal 
membrane  antigen  that  cross-reacted  with  antibody  raised  against  pep  M5  was 
isolated by affinity chromatography. Because immunoabsorption studies using serum 
from  rabbit  7907  indicated that  heart  tissue and  pep  M19  shared  the  same  cross- 
reactive antigenic determinant(s),  heart  cross-reactive antibodies were  first purified 
by affinity chromatography on a  column of pep M19 covalently linked to Sepharose 
beads. Specific antibody eluted from the column had an ELISA titer of 12,800 against 
both  pep  M19  and  pep  M5,  and  a  four plus  immunofluorescence  reaction against 
sarcolemmal membranes.  In contrast to the parent antiserum, the purified antibody 
failed to precipitate pep M5 as determined by agar gel diffusion. Neither the original 
serum  nor  the  purified  antibody  precipitated  pep  M19,  suggesting  that  the  cross- 
reactive antibody was directed against a  single, nonrepeating antigenic determinant 
on  each  pep  M  protein  (21).  The  purified  heart-reactive  antibodies  were  then 
covalently linked to CH-Sepharose, which was used to prepare an affinity column for 
the isolation of the cross-reactive antigen from human  heart tissue. 
The affinity-purified cross-reactive sarcolemmal membrane antigen migrated as a 
single polypeptide of-~215,000 mol wt in the unreduced state (Fig.  1 B). The purified 
antigen  corresponded  to  a  major  protein  band  in  the  crude  detergent  extract  of 1172  M  PROTEIN  HEART TISSUE  CROSS-REACTION 
sarcolemmal membranes (Fig. 1 A). Under reducing conditions, the antigen migrated 
as four distinct polypeptides ranging from 58,000 to 78,000 mol wt  (Fig.  1 D). Three 
of these polypeptides reacted with the pep M5 cross-reactive antiserum after electro- 
blot transfer (Fig.  1 E).  Taken together, these initial studies indicate that  the cross- 
reactive antigen of sarcolemmal membranes is a  complex protein composed of four 
peptide subunits linked by disulfide bonds; furthermore, three of the  four subunits 
were capable of binding the opsonic pep M5 heart cross-reactive antibodies. 
Discussion 
In these studies, we have demonstrated that type 5 streptococcal M  protein bears 
at  least one protective antigenic determinant that  is shared by human heart  tissue. 
Rabbit antiserum raised against a highly purified fragment of type 5 M  protein cross- 
reacted with sarcolemmal membranes of human heart and type 19 M  protein. All of 
the cross-reactive antibodies directed against human heart were absorbed by type 5 
as well as type  19 streptococci, and conversely, all of the opsonic antibodies reactive 
with type  19 organisms were absorbed by sarcolemmal membranes, indicating that 
the opsonic antibodies in the cross-reactive antiserum were directed against a common 
antigenic determinant shared  by sarcolemmal membranes and  types  5  and  19  M 
proteins. The most  definitive evidence that  the  tissue cross-reactive determinant is 
located  within the  M  protein molecule itself,  rather  than  a  contaminant, was  the 
finding that the cross-reactive antibodies eluted from sarcolemmal membranes opson- 
ized types 5 and 19 streptococci. 
The finding that the heart cross-reactive determinant was located on types 5 and 
FIc.  1.  SDS-PAGE  of affinity-purified  sarcolemmal membrane antigen of human heart that cross- 
reacts with pep M5 antibody. Detergent-extracted sarcolemmal membrane proteins (A) and the 
purified cross-reactive antigen  (B)  were prepared as  described in Materials and Methods and 
electrophoresed in the unreduced state on 7.5% SDS-polyacrylamide.  The molecular weight of the 
purified antigen (arrow) was calculated to be 2215,000. Electrophoresis  of the detergent extract (C) 
and purified antigen  (D)  on  10% SDS-polyacrylamide after treatment  with ~-mercaptoethanol 
revealed that the purified antigen was composed of four subunits of 78,000, 71,000, 65,000, and 
58,000 mol wt, respectively.  Autoradiography of electroblot transfer of the reduced subpeptides after 
incubating with pep M5 antiserum and 12SI-protein  A (E) showed that three of the polypeptides 
(arrows) bound  heart-reactive antibodies. Polyacrylamide gels were stained with  silver nitrate 
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19 M  proteins but on no other serotypes tested is in agreement with earlier studies by 
Kaplan  (2,  6), who demonstrated that  rabbits immunized with type 5 streptococci 
developed heart cross-reactive antibodies that were absorbed only by types 5 and  19 
cell walls:  he concluded that  the tissue cross-reactive antigen was  distinct  from M 
protein, even though it copurified with the type-specific M antigen (2). This conclusion 
was  based on the  finding that  type-specific moieties of type 5  M  protein could be 
separated  from the tissue cross-reactive antigen,  although  the cross-reactive moiety 
appeared to be inseparable from type-specific determinants (2).  Because subsequent 
studies  (11,  13,  14, 21-26) have shown that the M  protein molecule contains several 
distinctly  different  type-specific  protective  determinants,  these  data  can  now  be 
interpreted more clearly. Kaplan's  studies  (2)  demonstrating M  type-specific heart 
cross-reactivity used hot HC1 extracts of M  protein.  It is known that  such extracts 
contain  a  number  of polypeptides,  each  of which  contain  type-specific antigenic 
determinants (22). Thus, it is probable that Kaplan separated these peptides into two 
populations, one of which contained type-specific determinants that were heart cross- 
reactive and the other of which contained additional type-specific determinants that 
were not. This interpretation is also consistent with our data, which clearly show that 
types 5 and  19 M  proteins contain type-specific protective antigens in addition to the 
protective, heart cross-reactive antigen. The evidence is as follows. First, only one of 
nine rabbits  immunized with  pep  M5  and  none of six  immunized with  pep  M19 
developed heart cross-reactive antibodies, even though all of the rabbits  developed 
type-specific opsonic antibodies against the immunizing serotype. Second, absorption 
of the pep M5 cross-reactive antiserum (7907) with sarcolemmal membranes reduced 
opsonization of type 5 streptococci only minimally, indicating that the cross-reactive 
antiserum contained large amounts of type 5 opsonic antibodies in addition to the 
opsonic, cross-reactive antibodies. Finally, the purified heart cross-reactive antibody 
failed to precipitate pep M5 or pep M19, suggesting that  this antibody is directed 
against a distinct, nonrepeating antigenic determinant (21). 
In  addition  to  these  serotype-restricted,  heart  cross-reactive  antigens,  group  A 
streptococci contain heart cross-reactive antigens associated with structures other than 
the M  protein. Zabriskie and Freimer (3)  described heart-reactive antibodies raised 
against  purified  protoplast  membranes  of many  different  serotypes  of group  A 
streptococci. Furthermore, the cross-reactive antibodies  that  could  be absorbed  by 
heterologous serotypes of group A  streptococcal membranes also could be absorbed 
by membranes  from groups C  and  G  streptococci. Kaplan  (5)  also reported heart- 
reactive antibodies raised against whole group A streptococci that were absorbed by 
cell walls derived from many heterologous serotypes. In a  recent study, van de Rijn 
et al.  (8)  isolated a  family of four protoplast  membrane proteins that  reacted with 
antibodies in the sera of rheumatic subjects. Taken together, these studies suggest that 
group  A  streptococci contain  several  antigens  capable  of evoking antibodies  that 
cross-react with cardiac myofibers; a protective antigenic determinant shared by types 
5 and  19 M  proteins, a common protoplast membrane antigen(s), and a common cell 
wall antigen(s). The extent to which these antigenic determinants are different from 
each other remains to be elucidated. 
We have used purified pep M5 heart-reactive antibodies to isolate a cross-reactive 
antigen from sarcolemmal membranes of human heart. The antigen consists of a large 
polypeptide  (--215,000  mol  wt)  composed  of subunits  apparently  cross-linked  by 1174  M PROTEIN  HEART TISSUE CROSS-REACTION 
disulfide bonds; three of the reduced subunits reacted with the pep M5 cross-reactive 
antiserum.  Although  there  is  no  evidence  by  any  means  that  heart  cross-reactive 
antibodies raised by streptococcal products are injurious  to heart tissue in vivo, the 
continued studies of the immunological cross-reactions between structurally defined 
protein antigens of bacteria and specific membrane proteins of the animal host may 
provide new insights into the pathogenesis of autoimmune diseases in general. 
In conclusion, our studies provide the most definitive evidence that a  heart cross- 
reactive antigenic determinant is inherent in the structure of certain streptococcal M 
proteins.  It  is  clear,  however,  that  these  M  proteins  contain  additional  protective 
antigenic  determinants  (probably  the  majority)  that  are  not  heart  cross-reactive. 
These studies emphasize the need to isolate and identify subpeptides of M  proteins 
that  contain  protective, as opposed to  tissue cross-reactive, antigenic  determinants. 
Identification  and perhaps synthesis of protective and  tissue cross-reactive peptides 
would be important not only for the development of safe streptococcal vaccines, but 
also in elucidating the pathogenesis of acute rheumatic heart disease. 
Summary 
We present definitive evidence that at least one protective antigenic determinant 
on type 5  M  protein of group A  streptococci evokes antibody that  is cross-reactive 
with human heart tissue. One of nine rabbits immunized with a peptide fragment of 
type 5 M  protein (pep M5) produced antibody that cross-reacted by immunofluores- 
cence  with  sarcolemmal  membranes  of human  heart,  The  cross-reactive antibody 
could be removed by absorbing the antiserum with sarcolemmal membranes, types 5 
and 19 streptococci, or their pepsin-extracted M  proteins, but with no other serotypes 
tested. Although each of the pep M5 immune sera was opsonic for type 5 streptococci, 
only the heart-reactive antiserum opsonized type 19 streptococci. The opsonization of 
type  19  streptococci  was  abolished  by  absorbing  the  antiserum  with  sarcolemmal 
membranes  isolated  from  human  heart  tissue.  Purified  heart-reactive  antibodies 
eluted  from sarcolemmal  membranes opsonized  both  types  5  and  19  streptococci, 
indicating  that  the  heart  cross-reactive determinant  of type  5  M  protein  is  cross- 
protective. The cross-reactive antigen was purified by affinity chromatography from 
detergent extracts ofsarcolemmal membranes and determined to be a complex protein 
composed of four subunits apparently linked by disulfide bonds. 
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